Replies to post #416151 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Newly available preliminary efficacy results of surrogate biomarkers from the ANAVEX®2-73-AD-004 study; allowing initiation of discussions with regulatory agencies for Accelerated Approval Pathway for ANAVEX®2-73 (blarcamesine) in Alzheimer’s disease with convenient oral treatment

https://www.anavex.com/post/anavex-life-sciences-reports-fiscal-2023-second-quarter-financial-results

Good luck and GOD bless,

[Phoenix64]

The US market is clearly corrupt as evidenced by numerous credible posters here. TGA or EMU is the best pathway. Dr Missling knows that. The FDA will continue to drag feet because BIIB and LILY are lining their pockets. Our only hope to establish is Rett or Parkinson’s. They will not give the holy grail of AD to AVXL

[tredenwater2]

If it were me, I would put forth a push to seek approval in Australia,

I cant help but think Dr. Missling is pushing hard here. Who better than AU to affirm our trial results with approval, especially after running multiple AD trials, OLE’s, their own Rett Syndrome trial, and own PDD trial. What was the purpose of all those surprising trial initiations?

Commercialization comments?